Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan, Zhengzhou 450052, China.
Henan Joint International Pediatric Urodynamic Laboratory, The First Affiliated Hospital of Zhengzhou University, Henan, Zhengzhou 450052, China.
Int J Med Sci. 2024 Aug 19;21(11):2215-2232. doi: 10.7150/ijms.99992. eCollection 2024.
Protein information is often replaced by RNA data in studies to understand cancer-related biological processes or molecular functions, and proteins of prognostic significance in Kidney clear cell carcinoma (KIRC) remain to be mined. The cancer genome atlas program (TCGA) data was utilized to screen for proteins that are prognostically significant in KIRC. Machine learning algorithms were employed to develop protein prognostic models. Additionally, immune infiltration abundance, somatic mutation differences, and immunotherapeutic responses were analyzed in various protein risk subgroups. Ultimately, the validation of protein-coding genes was confirmed by utilizing an online database and implementing quantitative real-time PCR (qRT-PCR). The patients were divided into two risk categories based on prognostic proteins, and notable disparities in both overall survival (OS) and progression free interval (PFI) were observed between the two groups. The OS was more unfavorable in the high-risk group, and there was a noteworthy disparity in the level of immune infiltration observed between the two groups. In addition, the nomogram showed high accuracy in predicting survival in KIRC patients. In this research, we elucidated the core proteins associated with prognosis in terms of survival prediction, immunotherapeutic response, somatic mutation, and immune microenvironment. Additionally, we have developed a reliable prognostic model with excellent predictive capabilities.
在研究与癌症相关的生物过程或分子功能时,蛋白质信息经常被 RNA 数据所取代,而在肾透明细胞癌(KIRC)中具有预后意义的蛋白质仍有待挖掘。本研究利用癌症基因组图谱计划(TCGA)的数据筛选出 KIRC 中具有预后意义的蛋白质。采用机器学习算法构建蛋白质预后模型,并对不同蛋白风险亚组的免疫浸润丰度、体细胞突变差异和免疫治疗反应进行分析。最终,通过利用在线数据库和实施定量实时 PCR(qRT-PCR)验证蛋白编码基因。根据预后蛋白将患者分为两个风险类别,两组之间的总生存期(OS)和无进展生存期(PFI)存在显著差异。高危组的 OS 更不利,两组之间的免疫浸润水平存在显著差异。此外,列线图在预测 KIRC 患者的生存方面表现出较高的准确性。在这项研究中,我们阐明了与生存预测、免疫治疗反应、体细胞突变和免疫微环境相关的核心预后相关蛋白,并构建了一个具有优异预测能力的可靠预后模型。